TheEdgeResearch
Home / Stocks / KCE

State Street SPDR S&P Capital Markets ETF (KCE)

AMEX Financial Services Asset Management
$156.94 ▲ +0.33%
Market Cap
$447.3M
Sector
Financial Services
Industry
Asset Management
Beta
1.23
52-Wk Range
132.31-173.07
CEO
Pitharn Ongkosit
Country
US
Currency
USD

State Street SPDR S&P Capital Markets ETF operates in the Asset Management industry of the Financial Services sector, headquartered in Boston, MA, US. The stock last traded at $156.94, up 0.33% on the session, giving a market capitalisation of $447.3M. Its beta of 1.23 implies it has historically moved more than the broad market.

Company profile
Exchange
New York Stock Exchange Arca
Employees
8,119
IPO date
2005-11-15
Headquarters
Boston, MA, US
About State Street SPDR S&P Capital Markets ETF

KCE offers an equal-weighted portfolio of capital markets companies. These companies are defined as those publicly-traded names that do business as broker-dealers, asset managers, trust and custody banks or exchanges. The passively-managed fund selects its constituents based on market cap and its equal-weighting strategy causes the fund to tilt much smaller than our benchmark, with all of the associated risks that go along with it. Although the fund launched in 2005, it underwent a material index change in October 2011. The fund's exposure is predominantly investment management companies such as State Street, Northern Trust, and Charles Schwab, and its concentrated portfolio is relatively evenly split between large-, mid-, and small-cap securities giving it exposure to the full size spectrum of capital markets companies. The underlying index is rebalanced quarterly. Prior to Oct. 31, 2025 the Issuer did not use the branding of State Street in the fund name.

Comparable companies

State Street SPDR S&P Capital Markets ETF is most often compared with the following Financial Services names:

BKMCEESFLTWGIIIGEIHEIYMJHSCNUDMONEV
More research on KCE
KCE technical analysis KCE TheEdge Score Compare against peers
Open full interactive analysis & DCF →